Dianthus Therapeutics Grants Options on 87,000 Shares to Six New Hires
The clinical-stage biotech said it issued non-qualified stock options covering 87,000 shares at an exercise price of $106.02 to six newly hired non-executive employees, using the Nasdaq rule that lets companies skip a shareholder vote for hiring incentives.